Proton Therapy for Hodgkin Lymphoma
| Status: | Completed |
|---|---|
| Conditions: | Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 6 - Any |
| Updated: | 2/2/2019 |
| Start Date: | August 2009 |
| End Date: | January 9, 2018 |
Improving the Therapeutic Ratio by Using Proton Beam Radiation Therapy for Patients With Stage IA-IIIBX (Bulky/Non-bulky) Hodgkin Lymphoma Involving the Mediastinum Following Standard Chemotherapy
The purpose of this study is to reduce the risk of radiation related side effects and
complications by treating with radiation (protons or photons) that exposes less of normal
organs to low dose radiation.
complications by treating with radiation (protons or photons) that exposes less of normal
organs to low dose radiation.
3 treatment plans will be created to deliver between a total of 21-39.6 Gray (Gy)/Centigray
Equivalents (CGE) to the planning target volume (PTV).
1. Proton Plan
2. Conventional Plan
3. Intensity Modulated Radiotherapy (IMRT) Plan
The patient will then receive the radiation modality with the lowest percentage of the body
receiving 4 Gy (V4Gy/CGE)
Equivalents (CGE) to the planning target volume (PTV).
1. Proton Plan
2. Conventional Plan
3. Intensity Modulated Radiotherapy (IMRT) Plan
The patient will then receive the radiation modality with the lowest percentage of the body
receiving 4 Gy (V4Gy/CGE)
Inclusion Criteria:
- Confirmed "classic" Hodgkin lymphoma.
- Completed chemotherapy.
Exclusion Criteria:
- Prior radiotherapy.
- Prior or concurrent cancer other than non-melanomatous skin cancer.
We found this trial at
1
site
2015 Jefferson St
Jacksonville, Florida 32206
Jacksonville, Florida 32206
(904) 588-1800
University of Florida Proton Therapy Institute When the University of Florida Proton Therapy Institute opened...
Click here to add this to my saved trials
